AI & Regulation: AdvaMed Aims To Mold Artificial Intelligence Policy For Device Industry

As AI becomes more prevalent in the medical device arena, thought-leaders in industry and US FDA are looking down the road at how artificial intelligence can be regulated in a way that doesn't stymie innovation. AdvaMed is helping to lead the charge by crafting policy points to address the issue.

More from AI

More from Digital Technologies